ConductScience.org, home

Trial · NCT05934110

Registered outcomes35

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryRelative (%) change from baseline in body weight at week 26Baseline and week 26Efficacy endpoints
PrimaryProportion of participants with ≥5% decrease in body weight at week 26 [Please note: This is an FDA required outcome, cannot use "change"]Baseline and week 26Efficacy endpoints
SecondaryRelative (%) change from baseline in body weight at week 26 (secondary and exploratory comparisons)Baseline and week 26Efficacy endpoints
SecondaryProportion of participants with ≥5% (secondary and exploratory comparisons) and ≥10% (all comparisons) decrease in body weight at week 18 and week 26Baseline, week 18 and 26Efficacy endpoints
SecondaryAbsolute change from baseline in body weight at week 26Baseline and week 26Efficacy endpoints
SecondaryRelative (%) change from baseline in body weight during the 26-weeks treatment periodBaseline to week 26Efficacy endpoints
SecondaryAbsolute change from baseline in body weight during the 26-weeks treatment periodBaseline to week 26Efficacy endpoints
SecondaryAbsolute change from baseline in body mass index (BMI) measured as weight (kg) divided by height (m) squaredBaseline and week 26Efficacy endpoints
SecondaryAbsolute change from baseline in waist circumferenceBaseline and week 26Efficacy endpoints
SecondaryAbsolute change from baseline in sagittal diameterBaseline and week 26Efficacy endpoints
SecondaryAbsolute change from baseline in percentage body fatBaseline and week 26Efficacy endpoints
SecondaryAbsolute change from baseline in Quality of life as measured by the questionnaire Rand-36 (9 different domains)Baseline and week 26Efficacy endpoints
SecondaryAbsolute change from baseline in Quality of life as measured by the questionnaire EQ-5D-5L (measured as one summative value)Baseline and week 26Efficacy endpoints
SecondaryAbsolute change from baseline in self reported meal pattern. Short questionnaire where points are depending on adherence to the Nordic Nutrition recommendationsBaseline and week 26Efficacy endpoints.
SecondaryAbsolute change from baseline in self reported sleep, where higher points are given for good sleep duration and good sleep qualityBaseline and week 26Efficacy endpoints
SecondaryAbsolute change from baseline in self reported physical activity, where higher points are given for longer duration of moderate and intense physical activityBaseline and week 26Efficacy endpoints
SecondaryAbsolute change from baseline in fasting hemoglobin A1c (HbA1c)Baseline and week 26Efficacy endpoints
SecondaryAbsolute change from baseline in fasting glucoseBaseline and week 26Efficacy endpoints
SecondaryAbsolute change from baseline in fasting insulinBaseline and week 26Efficacy endpoints
SecondaryAbsolute change from baseline in fasting total cholesterolBaseline and week 26Efficacy endpoints

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05934110/registered